Annual CFI
N/A
December 31, 2023
Summary
- LIXT annual cash flow from investing activities is not available.
Performance
LIXT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
N/A
September 30, 2024
Summary
- LIXT quarterly cash flow from investing activities is not available.
Performance
LIXT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
N/A
September 30, 2024
Summary
- LIXT TTM cash flow from investing activities is not available.
Performance
LIXT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
LIXT Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
LIXT Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time |
Lixte Biotechnology Holdings Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2016 | $104.10 K(-5.0%) | $0.00(-100.0%) | $104.00 K(-80.2%) |
Sep 2016 | - | $1.05 M(-674.8%) | $524.00 K(+649.6%) |
Jun 2016 | - | -$183.40 K(-76.1%) | $69.90 K(-84.3%) |
Mar 2016 | - | -$766.70 K(-282.5%) | $446.00 K(+306.9%) |
Dec 2015 | $109.60 K(-152.8%) | $420.00 K(-30.0%) | $109.60 K(-70.3%) |
Sep 2015 | - | $600.00 K(+211.4%) | $369.60 K(+431.0%) |
Jun 2015 | - | $192.70 K(-117.5%) | $69.60 K(-105.3%) |
Mar 2015 | - | -$1.10 M(-262.2%) | -$1.31 M(+531.6%) |
Dec 2014 | -$207.60 K(<-9900.0%) | $680.00 K(+126.7%) | -$207.50 K(-76.6%) |
Sep 2014 | - | $300.00 K(-125.3%) | -$887.50 K(-25.3%) |
Jun 2014 | - | -$1.19 M(<-9900.0%) | -$1.19 M(<-9900.0%) |
Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2013 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2013 | - | $0.00(0.0%) | $0.00(-100.0%) |
Mar 2013 | - | $0.00(0.0%) | $75.00 K(-78.3%) |
Dec 2012 | $345.00 K(-72.4%) | $0.00(0.0%) | $345.00 K(-56.6%) |
Sep 2012 | - | $0.00(-100.0%) | $795.00 K(-38.6%) |
Jun 2012 | - | $75.00 K(-72.2%) | $1.29 M(-14.8%) |
Mar 2012 | - | $270.00 K(-40.0%) | $1.52 M(+21.6%) |
Dec 2011 | $1.25 M | $450.00 K(-10.0%) | $1.25 M(+25.0%) |
Sep 2011 | - | $500.00 K(+66.7%) | $999.80 K(+29.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2011 | - | $300.00 K(>+9900.0%) | $774.10 K(+63.3%) |
Mar 2011 | - | $0.00(-100.0%) | $474.00 K(-130.1%) |
Dec 2010 | -$1.58 M(+6204.0%) | $199.80 K(-27.2%) | -$1.58 M(-12.5%) |
Sep 2010 | - | $274.30 K(<-9900.0%) | -$1.80 M(-13.2%) |
Jun 2010 | - | -$100.00(-100.0%) | -$2.08 M(+0.0%) |
Mar 2010 | - | -$2.05 M(+8100.0%) | -$2.08 M(+8200.0%) |
Dec 2009 | -$25.00 K(<-9900.0%) | -$25.00 K(<-9900.0%) | -$25.00 K(<-9900.0%) |
Sep 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2008 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2008 | - | $0.00(0.0%) | $0.00(-100.0%) |
Dec 2007 | -$300.00(-40.0%) | $0.00(0.0%) | -$300.00(-50.0%) |
Sep 2007 | - | $0.00(0.0%) | -$600.00(0.0%) |
Jun 2007 | - | $0.00(-100.0%) | -$600.00(0.0%) |
Mar 2007 | - | -$300.00(0.0%) | -$600.00(+20.0%) |
Dec 2006 | -$500.00(<-9900.0%) | -$300.00(<-9900.0%) | -$500.00(+150.0%) |
Sep 2006 | - | $0.00(0.0%) | -$200.00(0.0%) |
Jun 2006 | - | $0.00(-100.0%) | -$200.00(0.0%) |
Mar 2006 | - | -$200.00 | -$200.00 |
Dec 2005 | $0.00 | - | - |
FAQ
- What is the all time high annual CFI for Lixte Biotechnology Holdings?
- What is the all time high quarterly CFI for Lixte Biotechnology Holdings?
- What is the all time high TTM CFI for Lixte Biotechnology Holdings?
What is the all time high annual CFI for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high annual cash flow from investing activities is $1.25 M
What is the all time high quarterly CFI for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high quarterly cash flow from investing activities is $1.05 M
What is the all time high TTM CFI for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high TTM cash flow from investing activities is $1.52 M